Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
953,812
-
Share change
-
+3,070
-
Total reported value
-
$2,575,000
-
Price per share
-
$2.70
-
Number of holders
-
11
-
Value change
-
-$72,850
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of Innate Pharma SA - SPONSORED ADS (IPHA) as of Q2 2022
As of 30 Jun 2022,
Innate Pharma SA - SPONSORED ADS (IPHA) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
953,812 shares.
The largest 10 holders included
BlackRock Inc., Optiver Holding B.V., BANK OF AMERICA CORP /DE/, MORGAN STANLEY, TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, UBS Group AG, Tower Research Capital LLC (TRC), BARCLAYS PLC, and CREDIT SUISSE AG/.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.